.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Farmers Insurance
Daiichi Sankyo
Julphar
Chinese Patent Office
Fish and Richardson
Cerilliant
Citi
Fuji

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071093

« Back to Dashboard
NDA 071093 describes THIOTHIXENE, which is a drug marketed by Am Therap, Watson Labs, Sandoz, Mylan, Paco, Teva Pharms, Alpharma Us Pharms, Teva, and Cycle Pharms Ltd, and is included in twenty NDAs. It is available from seven suppliers. Additional details are available on the THIOTHIXENE profile page.

The generic ingredient in THIOTHIXENE is thiothixene hydrochloride. There are five drug master file entries for this compound. Additional details are available on the thiothixene hydrochloride profile page.

Summary for NDA: 071093

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 071093

Suppliers and Packaging for NDA: 071093

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THIOTHIXENE
thiothixene
 CAPSULE;ORAL 071093 ANDA Mylan Pharmaceuticals Inc. 0378-1001 0378-1001-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1001-01)
THIOTHIXENE
thiothixene
 CAPSULE;ORAL 071093 ANDA Mylan Pharmaceuticals Inc. 0378-2002 0378-2002-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2002-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Jun 23, 1987TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength1MG
Approval Date:Jun 23, 1987TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength2MG
Approval Date:Jun 23, 1987TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Express Scripts
Cerilliant
QuintilesIMS
McKesson
Moodys
UBS
Colorcon
Dow
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot